Latin America Advanced Wound Care Market by Product, Wound Type, End User, Region

List of Tables

The LATAM advanced wound care market is projected to reach USD 498.2 million by 2030 from USD 312.8 million in 2025, at a CAGR of 9.8% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2024-2030
Units Considered	Value (USD million)
Segments	Product, wound type, end user, and countries
Regions covered	Brazil, Mexico, Colombia, Argentina, Peru, Chile, and the rest of Latin America

The growth of the LATAM advanced wound care market is primarily driven by the rising incidence of chronic conditions that hinder wound healing, the growing geriatric population, and the emergence of age-related syndromes. The increasing prevalence of diabetes and obesity further accelerates this trend. Moreover, the surge in burn injuries, trauma cases, and road accidents has increased the demand for effective advanced wound care solutions. However, the high cost of advanced wound care products and the potential risks associated with their use pose challenges to market expansion. Despite these barriers, the ongoing development of healthcare infrastructure and the adoption of advanced technologies present substantial opportunities for market growth.

By end user, the hospitals & clinics segment of the LATAM advanced wound care market accounted for the largest market share in 2024.

Based on end users, the LATAM advanced wound care market is divided into hospitals & clinics, ambulatory surgery centers, home care settings, and other end users. In 2024, hospitals & clinics accounted for the largest share of the Latin American advanced wound care market due to their ability to manage a high volume of chronic and complex wound cases, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, as well as their advanced infrastructure, availability of specialized care, and rising hospital admissions linked to chronic wounds and hospital-acquired infections.

By application, the chronic wounds segment accounted for the largest market share of the LATAM advanced wound care market.

The LATAM advanced wound care market is segmented into acute and chronic wounds. The chronic wounds segment accounted for the largest market share in 2024, primarily due to the rising number of traffic accidents, workplace injuries, and other trauma-related incidents requiring immediate medical care. The increasing number of surgical procedures for chronic wounds and the importance of treatments for peri-operative wounds are also expected to contribute to the market growth of this segment.

The chronic wounds segment is further divided into diabetic foot ulcers, pressure ulcers, and other chronic wounds, each requiring specialized products for treatment. Diabetic foot ulcers and pressure ulcers are common & expensive, highlighting the critical nature of the market. Advanced wound care solutions are essential for managing chronic wounds, particularly for enhanced patient safety and efficient wound care procedures.

By region, Mexico is expected to grow at the highest CAGR during the forecast period.

The LATAM advanced wound care market is segmented into Brazil, Mexico, Argentina, Colombia, Peru, Chile, and the rest of Latin America. The market in Mexico is expected to grow at the highest CAGR during the forecast period, owing to the expansion of the geriatric population, the rising healthcare costs, and the increasing incidence of chronic wounds. Mexico is expected to grow at the highest CAGR of 11.8% during the forecast period. Additionally, the growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. As wound care awareness improves and healthcare services advance, the demand for LATAM advanced wound care solutions in Mexico will contribute to market growth during the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-20%, Tier 2-45%, and Tier 3-35%
By Designation: C-level-30%, Director-level-20% and Others-50%
By Region: Brazil-35%, Mexico-25%, Argentina-10%, Chile- 8%, Colombia - 7%, Peru-5%, and the rest of Latin America-10%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The leading players operating in the LATAM advanced wound care market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Molnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), and AVERY DENNISON CORPORATION (US).

Research Coverage

This report studies the LATAM advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments relating to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights into the following points:

Analysis of Key DROCs: Drivers (the increasing incidence of chronic conditions impairing wound healing, the rising incidence of burn injuries, the growing number of trauma cases and road accidents); restraints (high cost of advanced wound care products, risk associated with advanced wound care products); opportunities (expansion of healthcare infrastructure & uptake of advanced technologies and universal health coverage); and challenges (shortage of skilled healthcare professionals, complications associated with delayed diagnosis, and limited awareness)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the LATAM advanced wound care market
Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the LATAM advanced wound care market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the LATAM advanced wound care market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Product Code: MD 9354

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Primary sources
  - 2.1.2.2 Key industry insights
  - 2.1.2.3 Key data from primary sources
  - 2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
  - 2.2.1.1 Approach 1: Company revenue estimation approach
  - 2.2.1.2 Approach 2: Presentations of companies and primary interviews
  - 2.2.1.3 Approach 3: Primary interviews
  - 2.2.1.4 Growth forecast
  - 2.2.1.5 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
- 2.4.1 STUDY-RELATED ASSUMPTIONS
- 2.4.2 PARAMETRIC ASSUMPTIONS
- 2.4.3 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 LATAM ADVANCED WOUND CARE MARKET OVERVIEW
4.2 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY END USER AND WOUND TYPE (2024)
4.3 LATAM ADVANCED WOUND CARE MARKET, BY KEY COUNTRY
4.4 COUNTRY MIX: LATAM ADVANCED WOUND CARE MARKET, 2024

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing incidence of chronic conditions impairing wound healing
    - 5.2.1.1.1 Expansion of geriatric population and emergence of age-associated syndromes
    - 5.2.1.1.2 Rising incidence of diabetes
    - 5.2.1.1.3 Increasing cases of obesity
  - 5.2.1.2 Growing number of burn injuries
  - 5.2.1.3 Rising trauma cases and road accidents
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of advanced wound care products
  - 5.2.2.2 Risks associated with advanced wound care products
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Expansion of healthcare infrastructure and uptake of advanced technologies
  - 5.2.3.2 Universal health coverage
- 5.2.4 CHALLENGES
  - 5.2.4.1 Shortage of skilled healthcare professionals
  - 5.2.4.2 Complications associated with delayed diagnosis and limited awareness
5.3 PRICING ANALYSIS
- 5.3.1 INDICATIVE PRICING OF KEY PLAYERS, BY APPLICATION (2025)
- 5.3.2 AVERAGE SELLING PRICE TREND, BY COUNTRY, 2023-2025
- 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RESEARCH & DEVELOPMENT (R&D)
- 5.4.2 MANUFACTURING
- 5.4.3 DISTRIBUTION AND MARKETING & SALES
- 5.4.4 POST-SALES SERVICES
5.5 SUPPLY CHAIN ANALYSIS
- 5.5.1 PROMINENT COMPANIES
- 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
- 5.5.3 END USERS
5.6 ECOSYSTEM ANALYSIS
5.7 PORTER'S FIVE FORCES ANALYSIS
- 5.7.1 THREAT OF NEW ENTRANTS
- 5.7.2 THREAT OF SUBSTITUTES
- 5.7.3 BARGAINING POWER OF SUPPLIERS
- 5.7.4 BARGAINING POWER OF BUYERS
- 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
- 5.8.1 REGULATORY LANDSCAPE
  - 5.8.1.1 Brazil
  - 5.8.1.2 Mexico
  - 5.8.1.3 Colombia
  - 5.8.1.4 Argentina
  - 5.8.1.5 Peru
  - 5.8.1.6 Chile
- 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
  - 5.9.1.1 Portable Negative Pressure Wound Therapy (NPWT) devices
- 5.9.2 ADJACENT TECHNOLOGIES
  - 5.9.2.1 Telemedicine for wound care
- 5.9.3 COMPLEMENTARY TECHNOLOGIES
  - 5.9.3.1 Antimicrobial wound dressings
5.10 TRADE ANALYSIS
- 5.10.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS
5.11 PATENT ANALYSIS
5.12 KEY CONFERENCES & EVENTS, 2025
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 BUYING CRITERIA
5.15 IMPACT OF AI/GENERATIVE AI ON LATAM ADVANCED WOUND CARE MARKET
- 5.15.1 INTRODUCTION
- 5.15.2 POTENTIAL OF AI IN ADVANCED WOUND CARE
- 5.15.3 AI USE CASES
- 5.15.4 FUTURE OF GENERATIVE AI ON ADVANCED WOUND CARE
5.16 INVESTMENT & FUNDING SCENARIO
5.17 CASE STUDY ANALYSIS
- 5.17.1 CASE STUDY 1: EFFECTIVE WOUND MANAGEMENT WITH BIATAIN SILICONE
- 5.17.2 CASE STUDY 2: ENHANCING WOUND CARE WITH MEPILEX UP
- 5.17.3 CASE STUDY 3: HYDROCOLL HYDROCOLLOID DRESSING SUPPORTS WOUND HEALING

6 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 FOAM DRESSINGS
- 6.2.1 SILICON DRESSINGS
  - 6.2.1.1 Bordered silicon dressings
    - 6.2.1.1.1 Gentle adhesive qualities to fuel uptake
  - 6.2.1.2 Non-bordered silicon dressings
    - 6.2.1.2.1 Highly absorbent foam core to boost adoption
- 6.2.2 NON-SILICON DRESSINGS
  - 6.2.2.1 High comfort and conformability to boost market
- 6.2.3 XEROFORM DRESSINGS
  - 6.2.3.1 Provision of bacteriostatic properties to fuel greater demand
- 6.2.4 HYDROCOLLOID DRESSINGS
  - 6.2.4.1 Increased functionality and enhanced collagen synthesis to drive market
- 6.2.5 FILM DRESSINGS
  - 6.2.5.1 Transparent and elastic properties to fuel uptake
- 6.2.6 ALGINATE DRESSINGS
  - 6.2.6.1 High incidence of burn injuries to boost market
- 6.2.7 GELLING DRESSINGS
  - 6.2.7.1 Effective management of moderate to heavy exuding wounds to support market growth
- 6.2.8 COLLAGEN DRESSINGS
  - 6.2.8.1 Inflammatory control and facilitation of protein synthesis to drive market
- 6.2.9 OTHER ADVANCED DRESSINGS

7 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE

7.1 INTRODUCTION
7.2 CHRONIC WOUNDS
- 7.2.1 DIABETIC FOOT ULCERS
  - 7.2.1.1 Increasing prevalence of diabetes to drive market
- 7.2.2 PRESSURE ULCERS
  - 7.2.2.1 Rising geriatric population and subsequent increase in comorbidities to fuel market
- 7.2.3 VENOUS LEG ULCERS
  - 7.2.3.1 Increasing prevalence of obesity to support market growth
- 7.2.4 OTHER CHRONIC WOUNDS
7.3 ACUTE WOUNDS
- 7.3.1 SURGICAL & TRAUMATIC WOUNDS
  - 7.3.1.1 Increasing volume of surgical procedures due to trauma & road accidents to fuel market
- 7.3.2 BURNS
  - 7.3.2.1 High incidence of burn injuries to support market growth

8 LATAM ADVANCED WOUND CARE MARKET, BY END USER

8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
- 8.2.1 RISING INCIDENCE OF HAIS TO DRIVE MARKET
8.3 AMBULATORY SURGERY CENTERS
- 8.3.1 PROVISION OF SPECIALIZED WOUND CARE SERVICES TO PROPEL MARKET
8.4 HOME CARE SETTINGS
- 8.4.1 LOW COSTS AND CONVENIENCE TO BOOST DEMAND
8.5 OTHER END USERS

9 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY

9.1 INTRODUCTION
9.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 9.2.1 BRAZIL
  - 9.2.1.1 Large healthcare sector to fuel demand
- 9.2.2 MEXICO
  - 9.2.2.1 Rising incidence of diabetes and chronic wounds to propel market
- 9.2.3 COLOMBIA
  - 9.2.3.1 Increasing incidence of venous ulcers to boost demand
- 9.2.4 ARGENTINA
  - 9.2.4.1 Increasing cases of burn injuries and trauma cases to support market growth
- 9.2.5 PERU
  - 9.2.5.1 Growing requirement for efficient wound healing management due to shortage of skilled professionals to fuel market
- 9.2.6 CHILE
  - 9.2.6.1 Improvements in healthcare infrastructure to support market growth
- 9.2.7 REST OF LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
- 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET
10.3 REVENUE ANALYSIS, 2021-2023
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY VALUATION AND FINANCIAL METRICS
- 10.5.1 COMPANY VALUATION
- 10.5.2 FINANCIAL METRICS
10.6 BRAND/PRODUCT COMPARISON
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 10.7.1 STARS
- 10.7.2 EMERGING LEADERS
- 10.7.3 PERVASIVE PLAYERS
- 10.7.4 PARTICIPANTS
- 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 10.7.5.1 Company footprint
  - 10.7.5.2 Region footprint
  - 10.7.5.3 Product footprint
  - 10.7.5.4 Wound type footprint
  - 10.7.5.5 End-user footprint
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 10.8.1 PROGRESSIVE COMPANIES
- 10.8.2 RESPONSIVE COMPANIES
- 10.8.3 DYNAMIC COMPANIES
- 10.8.4 STARTING BLOCKS
- 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 10.8.5.1 Detailed list of key startups/SMEs
  - 10.8.5.2 Competitive benchmarking of key startups/SMEs
10.9 COMPETITIVE SCENARIO
- 10.9.1 PRODUCT LAUNCHES
- 10.9.2 DEALS
- 10.9.3 EXPANSIONS
- 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

11.1 KEY PLAYERS
- 11.1.1 SOLVENTUM
  - 11.1.1.1 Business overview
  - 11.1.1.2 Products offered
  - 11.1.1.3 Recent developments
    - 11.1.1.3.1 Other developments
  - 11.1.1.4 MnM view
    - 11.1.1.4.1 Right to win
    - 11.1.1.4.2 Strategic choices
    - 11.1.1.4.3 Weaknesses & competitive threats
- 11.1.2 MOLNLYCKE AB
  - 11.1.2.1 Business overview
  - 11.1.2.2 Products offered
  - 11.1.2.3 Recent developments
    - 11.1.2.3.1 Deals
  - 11.1.2.4 MnM view
    - 11.1.2.4.1 Right to win
    - 11.1.2.4.2 Strategic choices
    - 11.1.2.4.3 Weaknesses & competitive threats
- 11.1.3 COLOPLAST GROUP
  - 11.1.3.1 Business overview
  - 11.1.3.2 Products offered
  - 11.1.3.3 Recent developments
    - 11.1.3.3.1 Deals
  - 11.1.3.4 MnM view
    - 11.1.3.4.1 Right to win
    - 11.1.3.4.2 Strategic choices
    - 11.1.3.4.3 Weaknesses & competitive threats
- 11.1.4 SMITH+NEPHEW
  - 11.1.4.1 Business overview
  - 11.1.4.2 Products offered
  - 11.1.4.3 Recent developments
    - 11.1.4.3.1 Deals
    - 11.1.4.3.2 Expansions
    - 11.1.4.3.3 Other developments
  - 11.1.4.4 MnM view
    - 11.1.4.4.1 Right to win
    - 11.1.4.4.2 Strategic choices
    - 11.1.4.4.3 Weaknesses & competitive threats
- 11.1.5 CONVATEC GROUP PLC
  - 11.1.5.1 Business overview
  - 11.1.5.2 Products offered
  - 11.1.5.3 Recent developments
    - 11.1.5.3.1 Product launches/approvals/enhancements
    - 11.1.5.3.2 Deals
  - 11.1.5.4 MnM view
    - 11.1.5.4.1 Right to win
    - 11.1.5.4.2 Strategic choices
    - 11.1.5.4.3 Weaknesses & competitive threats
- 11.1.6 CARDINAL HEALTH
  - 11.1.6.1 Business overview
  - 11.1.6.2 Products offered
  - 11.1.6.3 Recent developments
    - 11.1.6.3.1 Expansions
- 11.1.7 B. BRAUN SE
  - 11.1.7.1 Business overview
  - 11.1.7.2 Products offered
  - 11.1.7.3 Recent developments
    - 11.1.7.3.1 Deals
    - 11.1.7.3.2 Expansions
- 11.1.8 ESSITY AKTIEBOLAG
  - 11.1.8.1 Business overview
  - 11.1.8.2 Products offered
  - 11.1.8.3 Recent developments
    - 11.1.8.3.1 Deals
    - 11.1.8.3.2 Expansions
- 11.1.9 PAUL HARTMANN AG
  - 11.1.9.1 Business overview
  - 11.1.9.2 Products offered
  - 11.1.9.3 Recent developments
    - 11.1.9.3.1 Deals
- 11.1.10 INTEGRA LIFESCIENCES CORPORATION
  - 11.1.10.1 Business overview
  - 11.1.10.2 Products offered
  - 11.1.10.3 Recent developments
    - 11.1.10.3.1 Deals
    - 11.1.10.3.2 Expansions
- 11.1.11 MATIV HOLDINGS, INC.
  - 11.1.11.1 Business overview
  - 11.1.11.2 Products offered
  - 11.1.11.3 Recent developments
    - 11.1.11.3.1 Deals
- 11.1.12 OWENS & MINOR
  - 11.1.12.1 Business overview
  - 11.1.12.2 Products offered
  - 11.1.12.3 Recent developments
    - 11.1.12.3.1 Deals
- 11.1.13 AVERY DENNISON CORPORATION
  - 11.1.13.1 Business overview
  - 11.1.13.2 Products offered
  - 11.1.13.3 Recent developments
    - 11.1.13.3.1 Deals
    - 11.1.13.3.2 Expansions
11.2 OTHER PLAYERS
- 11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG
- 11.2.2 MEDLINE INDUSTRIES, LP
- 11.2.3 FERRIS MFG. CORP.
- 11.2.4 TRIAGE MEDTECH
- 11.2.5 MISSNER & MISSNER LTDA
- 11.2.6 DEROYAL INDUSTRIES, INC.
- 11.2.7 HOLLISTER INCORPORATED
- 11.2.8 WINNER MEDICAL CO., LTD.
- 11.2.9 URGO MEDICAL
- 11.2.10 BAIHE MEDICAL
- 11.2.11 CREMER S.A.
- 11.2.12 ADVANCIS (UK)

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

Product Code: MD 9354

List of Tables

TABLE 1 LATAM ADVANCED WOUND CARE MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 LATAM ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT
TABLE 3 PEOPLE WITH DIABETES (20-79 YEARS), BY COUNTRY, 2021 VS. 2045 (IN THOUSANDS)
TABLE 4 PREVALENCE OF OVERWEIGHT ADULTS, BMI >= 25 KG/M2 (AGE-STANDARDIZED ESTIMATE) (%); 18+ YEARS IN LATIN AMERICA, MALE & FEMALE
TABLE 5 AVERAGE TREATMENT COST FOR DIABETIC FOOT ULCERS
TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
TABLE 7 INDICATIVE PRICE OF KEY PLAYERS FOR WOUND TYPE IN 2025 (USD)
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY COUNTRY, 2023-2025
TABLE 9 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
TABLE 10 LATAM ADVANCED WOUND CARE MARKET: ROLE IN ECOSYSTEM
TABLE 11 LATAM ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 12 LATIN AMERICA: LIST OF KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2020-2024 (USD MILLION)
TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2020-2024 (USD MILLION)
TABLE 15 LATAM ADVANCED WOUND CARE MARKET: KEY CONFERENCES & EVENTS, 2025
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 17 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY RANK
TABLE 18 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 19 KEY PRODUCTS OFFERED IN FOAM DRESSINGS MARKET
TABLE 20 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 21 LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 22 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 23 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 24 LATAM ADVANCED WOUND CARE MARKET FOR BORDERED DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 25 LATAM ADVANCED WOUND CARE MARKET FOR NON-BORDERED SILICON DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 26 LATAM ADVANCED WOUND CARE MARKET FOR NON-SILICON DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 27 KEY PRODUCTS OFFERED IN XEROFORM DRESSINGS MARKET
TABLE 28 LATAM ADVANCED WOUND CARE MARKET FOR XEROFORM DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 29 KEY PRODUCTS OFFERED IN HYDROCOLLOID DRESSINGS MARKET
TABLE 30 LATAM ADVANCED WOUND CARE MARKET FOR HYDROCOLLOID DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 31 KEY PRODUCTS OFFERED IN FILM DRESSINGS MARKET
TABLE 32 LATAM ADVANCED WOUND CARE MARKET FOR FILM DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 33 KEY PRODUCTS OFFERED IN ALGINATE DRESSINGS MARKET
TABLE 34 LATAM ADVANCED WOUND CARE MARKET FOR ALGINATE DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 35 KEY PRODUCTS OFFERED IN GELLING DRESSINGS MARKET
TABLE 36 LATAM ADVANCED WOUND CARE MARKET FOR GELLING DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 37 KEY PRODUCTS OFFERED IN COLLAGEN DRESSINGS MARKET
TABLE 38 LATAM ADVANCED WOUND CARE MARKET FOR COLLAGEN DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 39 OTHER ADVANCED DRESSINGS OFFERED
TABLE 40 LATAM ADVANCED WOUND CARE MARKET FOR OTHER ADVANCED DRESSINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 41 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 42 CHRONIC WOUNDS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 43 ACUTE WOUNDS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 44 CHRONIC WOUNDS MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 45 PREVALENCE OF DIABETES IN LATIN AMERICA, BY COUNTRY (2021)
TABLE 46 CHRONIC WOUNDS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 47 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS (THOUSANDS)
TABLE 48 CHRONIC WOUNDS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 49 CHRONIC WOUNDS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 50 OTHER CHRONIC WOUNDS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 51 ACUTE WOUNDS MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 52 ACUTE WOUNDS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 53 ACUTE WOUNDS MARKET FOR BURNS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 54 LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 55 HOSPITALS PER CAPITA, BY COUNTRY (2025)
TABLE 56 LATAM ADVANCED WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 57 LATAM ADVANCED WOUND CARE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 58 LATAM ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 59 LATAM ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 60 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 61 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 62 BRAZIL: MACROECONOMIC INDICATORS
TABLE 63 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 64 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 65 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 66 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 67 BRAZIL: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 68 BRAZIL: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 69 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 70 MEXICO: MACROECONOMIC INDICATORS
TABLE 71 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 72 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 73 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 74 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 75 MEXICO: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 76 MEXICO: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 77 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 78 COLOMBIA: MACROECONOMIC INDICATORS
TABLE 79 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 80 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 81 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 82 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 83 COLOMBIA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 84 COLOMBIA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 85 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 86 ARGENTINA: MACROECONOMIC INDICATORS
TABLE 87 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 88 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 89 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 90 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 91 ARGENTINA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 92 ARGENTINA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 93 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 94 PERU: MACROECONOMIC INDICATORS
TABLE 95 PERU: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 96 PERU: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 97 PERU: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 98 PERU: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 99 PERU: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 100 PERU: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 101 PERU: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 102 CHILE: MACROECONOMIC INDICATORS
TABLE 103 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 104 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 105 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 106 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 107 CHILE: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 108 CHILE: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 109 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 110 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 111 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 112 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 113 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 114 REST OF LATIN AMERICA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 115 REST OF LATIN AMERICA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022-2030 (USD MILLION)
TABLE 116 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2022-2025
TABLE 118 LATAM ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION
TABLE 119 LATAM ADVANCED WOUND CARE MARKET: REGION FOOTPRINT
TABLE 120 LATAM ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT
TABLE 121 LATAM ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT
TABLE 122 LATAM ADVANCED WOUND CARE MARKET: END-USER FOOTPRINT
TABLE 123 LATAM ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 124 LATAM ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 125 LATAM ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2025
TABLE 126 LATAM ADVANCED WOUND CARE MARKET: DEALS, JANUARY 2022-FEBRUARY 2025
TABLE 127 LATAM ADVANCED WOUND CARE MARKET: EXPANSIONS, JANUARY 2022-FEBRUARY 2025
TABLE 128 LATAM ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2025
TABLE 129 SOLVENTUM: COMPANY OVERVIEW
TABLE 130 SOLVENTUM: PRODUCTS OFFERED
TABLE 131 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021-FEBRUARY 2025
TABLE 132 MOLNLYCKE AB: COMPANY OVERVIEW
TABLE 133 MOLNLYCKE AB: PRODUCTS OFFERED
TABLE 134 MOLNLYCKE AB: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 135 COLOPLAST GROUP: COMPANY OVERVIEW
TABLE 136 COLOPLAST GROUP: PRODUCTS OFFERED
TABLE 137 COLOPLAST GROUP: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 138 SMITH+NEPHEW: COMPANY OVERVIEW
TABLE 139 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 140 SMITH+NEPHEW: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 141 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 142 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021-FEBRUARY 2025
TABLE 143 CONVATEC GROUP PLC: COMPANY OVERVIEW
TABLE 144 CONVATEC GROUP PLC: PRODUCTS OFFERED
TABLE 145 CONVATEC GROUP PLC: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2021-FEBRUARY 2025
TABLE 146 CONVATEC GROUP PLC: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 147 CARDINAL HEALTH: COMPANY OVERVIEW
TABLE 148 CARDINAL HEALTH: PRODUCTS OFFERED
TABLE 149 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 150 B. BRAUN SE: COMPANY OVERVIEW
TABLE 151 B. BRAUN SE: PRODUCTS OFFERED
TABLE 152 B. BRAUN SE: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 153 B. BRAUN SE: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 154 ESSITY AKTIEBOLAG: COMPANY OVERVIEW
TABLE 155 ESSITY AKTIEBOLAG: PRODUCTS OFFERED
TABLE 156 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 157 ESSITY AKTIEBOLAG: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 158 PAUL HARTMANN AG: COMPANY OVERVIEW
TABLE 159 PAUL HARTMANN AG: PRODUCTS OFFERED
TABLE 160 PAUL HARTMANN AG: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 161 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 162 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
TABLE 163 INTEGRA LIFESCIENCES: DEALS JANUARY 2021-FEBRUARY 2025
TABLE 164 INTEGRA LIFESCIENCES CORPORATION: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 165 MATIV HOLDINGS, INC.: COMPANY OVERVIEW
TABLE 166 MATIV HOLDINGS, INC.: PRODUCTS OFFERED
TABLE 167 MATIV HOLDINGS, INC.: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 168 OWENS & MINOR: COMPANY OVERVIEW
TABLE 169 OWENS & MINOR: PRODUCTS OFFERED
TABLE 170 OWENS & MINOR: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 171 AVERY DENNISON CORPORATION: COMPANY OVERVIEW
TABLE 172 AVERY DENNISON CORPORATION: PRODUCTS OFFERED
TABLE 173 AVERY DENNISON CORPORATION: DEALS, JANUARY 2021-FEBRUARY 2025
TABLE 174 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2021-FEBRUARY 2025
TABLE 175 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
TABLE 176 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW
TABLE 177 FERRIS MFG. CORP.: COMPANY OVERVIEW
TABLE 178 TRIAGE MEDTECH: COMPANY OVERVIEW
TABLE 179 MISSNER & MISSNER LTDA: COMPANY OVERVIEW
TABLE 180 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 181 HOLLISTER INCORPORATED: COMPANY OVERVIEW
TABLE 182 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW
TABLE 183 URGO MEDICA: COMPANY OVERVIEW
TABLE 184 BAIHE MEDICAL: COMPANY OVERVIEW
TABLE 185 CREMER S.A.: COMPANY OVERVIEW
TABLE 186 ADVANCIS (UK): COMPANY OVERVIEW

List of Figures

FIGURE 1 LATAM ADVANCED WOUND CARE MARKET: RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRIES
FIGURE 3 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 5 LATAM ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 8 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 9 LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 10 GEOGRAPHIC SNAPSHOT OF LATAM ADVANCED WOUND CARE MARKET
FIGURE 11 RISING INCIDENCE OF CHRONIC CONDITIONS AND AGE-ASSOCIATED SYNDROMES TO FUEL MARKET
FIGURE 12 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 13 MEXICO TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
FIGURE 14 BRAZIL ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 15 LATAM ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 LATAM ADVANCED WOUND CARE MARKET: VALUE CHAIN ANALYSIS
FIGURE 17 LATAM ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18 LATAM ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS
FIGURE 19 LATAM ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 20 LATAM ADVANCED WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015-MARCH 2024
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 23 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY END USER
FIGURE 24 INVESTMENT & FUNDING SCENARIO, 2020-2025
FIGURE 25 BRAZIL: LATAM ADVANCED WOUND CARE MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2023 (USD MILLION)
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 28 RANKING OF KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2024
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 30 FINANCIAL METRICS, 2025
FIGURE 31 LATAM ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARISON
FIGURE 32 LATAM ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 33 LATAM ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT
FIGURE 34 LATAM ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 35 SOLVENTUM: COMPANY SNAPSHOT (2024)
FIGURE 36 MOLNLYCKE AB: COMPANY SNAPSHOT (2023)
FIGURE 37 COLOPLAST GROUP: COMPANY SNAPSHOT (2024)
FIGURE 38 SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
FIGURE 39 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2023)
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2023)
FIGURE 42 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024)
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023)
FIGURE 44 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 45 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024)
FIGURE 46 OWENS & MINOR: COMPANY SNAPSHOT (2024)
FIGURE 47 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)

Latin America Advanced Wound Care Market by Product (Foam, Hydrocolloid, Film, Alginate, Collagen), Wound Type (Chronic (Diabetic Foot Ulcers, Pressure Ulcers), Acute (Surgical, Burns)), End User (Hospitals, Clinics, ASCs), Region - Forecast to 2030

Description

Table of Contents

List of Tables

A breakdown of the primary participants referred to for this report is provided below:

This report provides insights into the following points:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT

7 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE

8 LATAM ADVANCED WOUND CARE MARKET, BY END USER

9 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 APPENDIX

List of Tables

List of Figures